Profile for CollPlant Biotechnologies Ltd. (CLGN)

$ 9.20 r      0.20 (+2.22%) Volume: 8.11k 3:55 PM EDT Mar 31, 2020
Business Description:
Collplant Holdings Ltd is a biotechnology company focused on regenerative medicine. It focused on developing & commercializing tissue repair products. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants.
Address: 4 Oppenheimer, Weizmann Science Park, Rehovot, ISR, 7670104
Telephone: +972 732325600 Website: https://www.collplant.com
Facsimile: +972 732325602 Email: [email protected]
Details
CEO: Yehiel Tal
Employees: 40 Market Cap: 49.41m
Issue Type: CS
Auditor: Kesselman & Kesselman C.P.A.s
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1631487
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: N/A
SIC: